title: Elimination of Kupffer cells and administration of protease inhibitor improve graft viability and prevent reperfusion injury in NHBD.
authors.affiliation: Second Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Tsukamoto
authors.forename: N
authors.initials: N
authors.lastname: Ohkohchi
authors.forename: T
authors.initials: T
authors.lastname: Orii
authors.forename: T
authors.initials: T
authors.lastname: Fukumori
authors.forename: T
authors.initials: T
authors.lastname: Asakura
authors.forename: J
authors.initials: J
authors.lastname: Takayama
authors.forename: H
authors.initials: H
authors.lastname: Kato
authors.forename: S
authors.initials: S
authors.lastname: Satomi
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D004002:Clodronic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D004337:Drug Carriers; D004734:Energy Metabolism; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006323:Heart Arrest; D007728:Kupffer Cells / Q000166:cytology* / Q000187:drug effects; D008081:Liposomes; D016031:Liver Transplantation / Q000502:physiology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*; D013552:Swine; D014019:Tissue Donors
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D011480:Protease Inhibitors; D004002:Clodronic Acid; D000255:Adenosine Triphosphate